ASHLEE DUGGER: Open Payments
NPI 1215397898 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 14 payments from 6 companies in 2025. Trend: 2023 $1,937 · 2024 $1,712 · 2025 $459
Food & beverage: $359Education: $100
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 4 | $238 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| GENZYME CORPORATION | 2 | $53 |
| Verona Pharma, Inc. | 2 | $51 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $20 |
Products named: OPSUMIT, UPTRAVI, DUPIXENT, Ohtuvayre, FASENRA, BREZTRI, INSPIRE, Prolastin-C Liquid.
Industry payments across TX — which companies pay providers there.
